The Lancet: Journal Homepage
WEB5 days ago · The growing challenge of antimicrobial resistance (AMR) is now recognised as a global public health emergency that requires concerted efforts by all stakeholders. 1 There is compelling evidence that AMR is associated with increased mortality and longer hospitalisation, and has a negative effect on the economies of communities and countries, more so in low-income and middle-income countries ...
Global Burden of Disease - The Lancet
WEBWelcome to the Lancet Global Burden of Disease (GBD) Resource Centre, bringing together the most comprehensive data and analysis of worldwide trends in global health, published across the Lancet family of journals. All GBD Articles published with the Lancet journals are Open Access or otherwise free to read with registration.
The Lancet Haematology Home Page
WEB2 days ago · Published: September 6, 2024. Hide. In The Lancet Haematology, Gordon Cook and colleagues 1 report the results of a planned interim analysis of the multicentre, randomised, phase 3 ACCoRD trial done in the UK by the Myeloma Research Council. The trial aims to assess whether consolidation with …
Ageism: a social determinant of health that has come of age
WEBMar 18, 2021 · Ageism is the stereotypes, prejudice, and discrimination directed towards people on the basis of their age. It affects billions of people, harms health outcomes, and can be reduced by policy, education, and intergenerational contact interventions.
Global Burden of Disease 2019 - The Lancet
WEBOct 15, 2020 · The latest global disease estimates, published in The Lancet, analyses 286 causes of death in 204 countries and territories to reveal the state of the world’s health just before the COVID-19 pandemic. The Global Burden of Disease Study provides a roadmap to where need is greatest, with country-specific …
Global prevalence and burden of depressive and anxiety disorders …
WEBNov 6, 2021 · This study estimates the impact of the COVID-19 pandemic on the prevalence and burden of major depressive disorder and anxiety disorders in 204 countries and territories in 2020. It finds that the pandemic increased the prevalence of both disorders, especially among females and younger age groups, and that human mobility and daily SARS-CoV-2 infection rate were associated with higher prevalence.
Mitochondrial disease in adults: recent advances and future …
WEBThis article reviews the progress in understanding, diagnosis, and treatment of mitochondrial diseases, which are inherited neurometabolic disorders caused by defects in mitochondrial or nuclear genes. It covers the clinical spectrum, genetic causes, diagnostic tools, management strategies, and reproductive …
Comparative efficacy and tolerability of 32 oral antipsychotics for …
WEBSep 14, 2019 · A systematic review and network meta-analysis of 402 studies with 53 463 participants compared 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia. The study found some efficacy differences but more marked side-effects among antipsychotics.
Antiviral effect of high-dose ivermectin in adults with COVID-19: A ...
WEBJun 17, 2021 · This study evaluated the antiviral effect of oral ivermectin at 0.6 mg/kg/day for 5 days in hospitalized patients with COVID-19. It found a concentration dependent antiviral activity of ivermectin, but no difference in clinical outcome or viral load reduction compared to standard of care.
Azithromycin for mild-to-moderate COVID-19 - The Lancet
WEBSep 9, 2021 · A correspondence letter that comments on a randomised trial of azithromycin versus standard care in patients with mild-to-moderate COVID-19. The letter raises questions about the study design, inclusion criteria, compliance, and interpretation of …